Total planned funding: $310,020,243
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $85,877,686 |
Nigeria | $43,150,813 |
Kenya | $35,793,669 |
South Africa | $18,269,527 |
Burundi | $16,526,166 |
Ethiopia | $13,334,711 |
Botswana | $9,762,783 |
Vietnam | $9,255,315 |
Zambia | $9,168,101 |
Zimbabwe | $8,990,190 |
Tanzania | $7,506,556 |
Côte d'Ivoire | $7,293,449 |
Malawi | $5,970,663 |
Democratic Republic of the Congo | $5,508,286 |
Indonesia | $5,026,155 |
Haiti | $4,260,713 |
India | $3,723,000 |
Asia Regional Program | $3,654,954 |
Papua New Guinea | $3,189,171 |
Uganda | $3,060,518 |
Caribbean Region | $2,717,206 |
Eswatini | $2,043,924 |
Central America Region | $1,646,143 |
Angola | $1,085,000 |
South Sudan | $1,051,916 |
Cameroon | $700,000 |
Lesotho | $653,628 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Ghana | $0 |
Rwanda | $0 |
Organizational Types
NGO | $310,020,243 |
Program Areas
Care | $114,356,736 |
Treatment | $81,610,520 |
Prevention | $79,768,991 |
Testing | $19,868,295 |
Governance and Systems | $14,415,701 |
Budget Codes
HTXS: Treatment: Adult Treatment | $75,615,880 |
HKID: Care: Orphans and Vulnerable Children | $57,207,712 |
HBHC: Care: Adult Care and Support | $42,237,657 |
HVOP: Sexual Prevention: Other Sexual Prevention | $37,561,305 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $27,314,063 |
HVCT: Testing: HIV Testing and Counseling | $19,868,295 |
PDCS: Care: Pediatric Care and Support | $7,706,222 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,221,112 |
HVTB: Care: TB/HIV | $7,205,145 |
OHSS: Health Systems Strengthening | $6,522,503 |
PDTX: Treatment: Pediatric Treatment | $5,994,640 |
HVSI: Strategic Information | $4,736,899 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,185,814 |
HLAB: Laboratory Infrastructure | $3,156,299 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,919,281 |
HMIN: Biomedical Prevention: Injection Safety | $407,265 |
HMBL: Biomedical Prevention: Blood Safety | $160,151 |
HTXD: Treatment: ARV Drugs | $0 |